Liver transplantation is considered for individuals with end-stage liver disease, acute liver failure, or certain liver cancers when other medical treatments are no longer effective.

The waiting time for a liver transplant can vary depending on factors such as the availability of donor organs, the severity of the recipient’s condition, and the region’s organ allocation policies. It can range from a few months to several years.

The success rate of liver transplantation has significantly improved over the years. The success depends on various factors, including the recipient’s overall health, the quality of the donor organ, and adherence to post-transplant medications and follow-up care. Generally, the one-year survival rate is around 90%, and the five-year survival rate is around 70-80%.

Yes, liver transplantation can significantly improve a patient’s quality of life. Many individuals are able to resume normal activities, work, and engage in hobbies and social interactions. However, certain lifestyle modifications and regular medical follow-up are necessary to ensure the long-term success of the transplant.

Kidney transplantation is considered for individuals with end-stage kidney disease when their kidneys can no longer function adequately to sustain life. It is also an option for some cases of advanced kidney disease where the quality of life is significantly affected.

Eligibility for kidney transplantation is determined through a comprehensive evaluation process conducted by a specialized transplant team. Factors such as the severity of kidney disease, overall health condition, absence of active infections or malignancies, and the ability to comply with post-transplant care are considered.

Yes, living individuals can donate a kidney to a person in need. Living donor kidney transplantation has become a common practice and offers advantages such as reduced waiting time and better long-term outcomes.

The success rate of kidney transplantation has improved significantly over the years. The success depends on various factors, including the quality of the donor organ, the recipient’s overall health, and adherence to post-transplant medications and follow-up care. Generally, the one-year survival rate for kidney transplant recipients is around 95%, and the five-year survival rate is around 85-90%.

Bone marrow transplantation, also known as hematopoietic stem cell transplantation, is a procedure in which damaged or diseased bone marrow is replaced with healthy stem cells to restore the production of healthy blood cells.

The donor stem cells can be obtained from three main sources: the bone marrow (referred to as a bone marrow transplant), peripheral blood (referred to as a peripheral blood stem cell transplant), or umbilical cord blood (referred to as a cord blood transplant). The source depends on various factors, including the patient’s condition and the availability of a suitable donor.

The process typically involves several steps: conditioning or preparative regimen, where high-dose chemotherapy or radiation is administered to destroy the diseased cells; infusion of the donor stem cells; engraftment, when the transplanted stem cells start producing healthy blood cells; and the recovery phase, during which the patient’s immune system rebuilds.

Family members can be potential bone marrow donors, especially siblings who have a higher chance of being a close genetic match. However, other unrelated individuals or cord blood from public cord blood banks can also be used as donor sources.